Office safety meeting topics
Common Questions and Answers about Office safety meeting topics
safety
Thank you so much for attending our meeting on April 2. The turnout was wonderful! We hope that everyone got something out of the meeting. Thanks to the nurses and doctor who shared and all the great questions, we can each take something home.
Don't forget that the next meeting is July 9, 2009 and a Nutritionist will be joining us from Dr. Sherman's office.
Please feel free to post any questions and keep our great Q & A going from our last meeeting.
It depends on the cause of the rash. Have you tried calling your doctor's office and asking their opinion? I usually default to trying triple antibiotic cream and/or cortizone cream on rashes to try to clear them up myself before consulting a doctor. However, cortizone cream should not be used on the delicate skin of the face (unless instructed otherwise by a doctor), as it can cause thinning of tissues over time.
I'm new here ... forgive my ignorance. I'll give you the cliff note version of what's going on with me...
I was scheduled for L3-L4 discectomy / decompression and as a result of my pre-op testing and blood work. I was called by my surgeons office who indicated that i have a "Suspicious R-Wave" in my EKG and referred me to my family doctor.
Former FDA Reviewer Speaks Out About Intimidation, Retaliation and Marginalizing of Safety
The Food and Drug Administration (FDA) is often accused of serving industry at the expense of consumers. But even FDA defenders are shocked by reports this week of an institutionalized FDA spying program on its own scientists, lawmakers, reporters and academics that included an enemies list of "actors" and collaborators.
Well, my boyfriend has been in a similar situation. Not an abusive one or anything, but he feared for the safety of his kids whenever they went with their mother. He went to court to get full custody of the boys and that's what he based his case on. The fact that he feared for their safety. The only tricky part in YOUR situation is being able to prove that he's done something to make you think he would flee or try to harm the children in any way.
FDA Teleconference - May 23, 2011
The Food and Drug Administration (FDA) invites you to participate in a teleconference briefing to discuss two Direct Acting Antivirals (DAAs) for the treatment of hepatitis C, boceprevir and telaprevir, that were discussed at an April 27 -28, 2011 meeting of the FDA Antiviral Drugs Advisory Committee. DAAs represent a significant addition to the treatment approach for many patients.
//www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/4149-easl-2013-ns5a-inhibitor-gs-5816-looks-good-in-phase-1-study-now-in-phase-2
Safety and Efficacy of Sofosbuvir Plus GS-5816 With or Without Ribavirin in Treatment-naive Subjects With Chronic HCV Infection
http://clinicaltrials.gov/ct2/show/NCT01858766?
pretty unprofessional to be talking about non-work related topics out loud. at that point, i was seriously hoping that the machine to take the survey on customer service worked so i can vent about my experience with her in particular. shes lucky either the machine didnt work or i didnt know how to turn on the machine. lol anyway i laughed it off since i'm not the one with a parking citation.
I had heard his name and vice versa for a long time prior to meeting. He moved to the city I live in and then I heard his name even more. I felt like I knew a LOT about him prior to our meeting. I was at a big shebang of a party------- really fancy shmancy and I was all dolled up. At that party (probably in the cocktail line)---- I was introduced to my now husband. We kind of had an instant connection and from all the stories, we felt like we knew each other.
The data were presented in a late breaking oral presentation at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD).
JNJ-3989 is an investigational small interfering RNA (siRNA) that targets all hepatitis B virus (HBV) RNAs, thereby reducing levels of all viral proteins.
The company intends to submit a late-breaking abstract to present initial clinical data on ARO-HBV, if accepted, at the Liver Meeting® 2018, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD), being held in November. ARO-HBV leverages Arrowhead’s proprietary Targeted RNAi Molecule (TRiM™) technology.
Bruce Given, M.D.
Monday, May 23
The Food and Drug Administration (FDA) invites you to participate in a briefing to discuss two Direct Acting Antivirals (DAAs) for the treatment of hepatitis C, boceprevir and telaprevir, that were discussed at an April 27 - 28, 2011 meeting of the FDA Antiviral Drugs Advisory Committee. DAAs represent a significant addition to the treatment approach for many patients.
I was so scared too when I went to my first meeting, but the second I walked in they all made me feel comfortble and when I left that evening I felt great.
There are good and bad experiences there, but it's worth a shot to go to your first meeting. You will even pick up a welcome chip or keychain. You don't have to talk at all if you don't want, you can just listen. It's a great support group.
Recommended
